Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03931174 · ClinicalTrials.gov registry record · NA

Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics)

A NA study, sponsored by Brown University.

Completed
Registry status
NA
Development phase
780
Enrollment target

NCT03931174: Completed NA study, sponsored by Brown University.

NCT03931174 is a NA study that has completed, run by Brown University. The registered enrollment target is 780 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03931174, a NA study, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
780 participants
Enrollment target

Study Summary

There is an urgent need for effective treatments for patients with opioid use disorder (OUD). This study will train opioid treatment programs in an evidence-based behavioral treatment called contingency management (CM). Contingency management (i.e., motivational incentives for achieving pre-defined treatment goals) is one of the only behavioral interventions shown to improve patient treatment outcomes when combined with FDA-approved pharmacotherapy. Unfortunately, however, uptake of CM in opioid treatment programs remains low. In response to the urgent need for evidence-based behavioral OUD treatments, the investigators propose a large-scale type 3 hybrid trial comparing two comprehensive strategies to promote CM implementation as an adjunct to pharmacotherapy within opioid treatment programs. The control condition is the staff training strategy used by the New England Addiction Technology Transfer Center, which consists of didactic workshop, performance feedback, and staff coaching. The experimental condition is the ATTC strategy enhanced by external leadership coaching (using a model called Implementation Sustainment Facilitation; ISF) and provider incentives (using a model called Pay for Performance; P4P). A cluster randomized design trial will be conducted with 30 opioid treatment programs across New England. Centers will be randomized to one of the two implementation conditions (ATTC vs. enhanced-ATTC) over the 5 year project. At each opioid treatment program, data will be collected at multiple intervals from CM treatment providers, organizational leaders, and newly admitted patients. Additionally, patient charts will be randomly selected for review to examine sustainment. Data collection will include electronic medical record review, ratings of audio recordings by staff blind to condition, well-validated measures, and provider weekly report of patient encounter data. Specific Aims of the study are to experimentally compare the effect of the two conditions on

Primary Outcome

Provider-level measure of whether the provider delivered the target number of CM sessions (at least 10 sessions) to at least one patient based on based on electronic medical record review and data entered into a study-specific CM tracker tool for up to 25 charts per site (25 charts\*30 sites = 750 charts). Providers will report on patient encounters in the electronic medical record and the study-specific CM tracker tool, and for each encounter will report if CM was provided. Using patient level

Interventions

  • BEHAVIORAL Addiction Technology Transfer Center (ATTC) Training Strategy
  • BEHAVIORAL Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy

Trial Details

FieldValue
Enrollment Target 780 participants
Start Date 2019-04-09
Est. Completion 2024-07-31
Phase NA
Brown University

231 total trials

What the finished NCT03931174 record still lists

NCT03931174 is an interventional study that assigns participants to a tested intervention. The registered 780 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower).

The record links to 0 conditions, and to 2 interventions - of which Addiction Technology Transfer Center (ATTC) Training Strategy is the first listed.

NCT03931174 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03931174 about?

NCT03931174 is a clinical study titled "Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics)". There is an urgent need for effective treatments for patients with opioid use disorder (OUD). This study will train opioid treatment programs in an evidence-based behavioral treatment called contingency management (CM). Contingency management (i.e., motivational incentives for achieving pre-defined ...

What is the current status of trial NCT03931174?

This trial is currently completed. It is a NA study. The enrollment target is 780 participants. The study started on 2019-04-09. Estimated completion is 2024-07-31.

What interventions are being tested in trial NCT03931174?

The interventions under investigation include: Addiction Technology Transfer Center (ATTC) Training Strategy (BEHAVIORAL), Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03931174?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03931174's enrollment target sits among peer trials

780 141st of 2000 higher than 1,859 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05046613 · 780 participants

    Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

  • NCT05100862 · 780 participants · Phase 3

    A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  • NCT05513872 · 780 participants · Phase 1

    Overcoming Nicotine Dependence to Enable Quitting

  • NCT06310031 · 780 participants · NA

    Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03931174, the US trial registry maintained by the National Library of Medicine. NCT03931174 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.